Jordan Phelan

Jordan develops and implements worldwide patent strategies for early- and mid-stage biotechnology companies. She has extensive technical experience in DNA sequencing, chimeric antigen receptor T-cell (CAR-T) therapy, gene editing, gene therapy, complex biologics and antibody therapeutics. Her practice focuses on counseling clients regarding global patent strategy and life cycle management, drafting and prosecution of biotechnology applications, and preparation of competitive landscape and freedom-to-operate analyses. She also provides patent support in partnership, acquisition and licensing negotiations.